STAGE IIB PROSTATE CANCER AJCC V8
Clinical trials for STAGE IIB PROSTATE CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIB PROSTATE CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIB PROSTATE CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Shorter radiation may be safer for recurrent prostate cancer
Disease control Recruiting nowThis study tests whether a precise, short-course radiation therapy (SBRT) works as well as a slightly longer radiation approach for prostate cancer that has come back after surgery or spread to a few spots. About 118 men will receive either SBRT or hypofractionated radiotherapy. …
Matched conditions: STAGE IIB PROSTATE CANCER AJCC V8
Phase: PHASE3 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
Prostate cancer study: which drug spares the heart?
Knowledge-focused Recruiting nowThis study compares two hormone-lowering drugs, relugolix and leuprolide, in men with prostate cancer who are also receiving radiation. The goal is to see which drug causes fewer heart problems. Researchers will measure heart function and exercise ability before and after treatme…
Matched conditions: STAGE IIB PROSTATE CANCER AJCC V8
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:08 UTC